Latest Alexion Pharmaceuticals Stories
NEW YORK, May 18, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:
NEW YORK, May 8, 2015 /PRNewswire/ -- The fairness of the proposed acquisition of Synageva Biopharma Corp. ("GEVA" or the "Company") by Alexion Pharmaceuticals, Inc.
RnRMarketResearch.com adds "Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2015" to its store.
LONDON, February 10, 2015 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Investor-Edge has initiated coverage
CAMBRIDGE, Mass., Jan.
Editor Note: For more information about this release, please scroll to bottom. LONDON, October 24, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on
Editor Note: For more information about this release, please scroll to bottom. LONDON, September 10, 2014 /PRNewswire/ -- On Tuesday, September 09, 2014, the NASDAQ
LYNBROOK, N.Y., Aug. 5, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.